Average Co-Inventor Count = 6.31
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (12 from 2,078 patents)
2. Bristol-myers Squibb Compnay (9 from 3,684 patents)
3. Janssen Biotech, Inc. (4 from 410 patents)
4. Ortho-mcneil Pharmaceutical Corp. (4 from 363 patents)
29 patents:
1. 11597746 - Cyclic dinucleotides as sting agonists
2. 11492367 - Cyclic dinucleotides as sting agonists
3. 11472830 - Cyclic dinucleotides as sting agonists
4. 11021511 - Cyclic dinucleotides as sting agonists
5. 10954286 - Bispecific EGFR/IGFIR binding molecules
6. 10781247 - Targeted therapeutics based on engineered proteins that bind EGFR
7. 10183987 - Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
8. 9920108 - Targeted therapeutics based on engineered proteins that bind EGFR
9. 9771411 - Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules
10. 9234028 - Targeted therapeutics based on engineered proteins that bind EGFR
11. 9017655 - Bispecific EGFR/IGFIR binding molecules
12. 8524244 - Targeted therapeutics based on engineered proteins that bind EGFR
13. 8367825 - Substituted pyrimidinyl oxime kinase inhibitors
14. 8343501 - Bispecific EGFR/IGFIR binding molecules
15. 8314234 - Bicyclic pyrimidine kinase inhibitors